Factors influencing adherence to non-vitamin K antagonist oral anticoagulants in the early period after atrial fibrillation catheter ablation in China

In patients with AF, anxiety mainly arises from fear of both symptoms of AF and thromboembolic events. Since anticoagulation is the primary method to prevent thromboembolic events, it is reasonable that anxiety makes patients with AF adhere to NOAC treatment. The reason for early anticoagulant thera...

Full description

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2020-08, Vol.133 (16), p.1989-1991
Main Authors: Hu, Zhi-Cheng, Liu, Shang-Yu, Wu, Ling-Min, Shen, Li-Shui, Liu, Li-Min, Li, Guo-Liang, Zheng, Li-Hui, Yao, Yan
Format: Article
Language:English
Subjects:
Ablation
Administration, Oral
Anticoagulants
Anticoagulants - therapeutic use
Anxiety
Atrial Fibrillation - drug therapy
Atrial Fibrillation - surgery
Cardiac arrhythmia
Catheter Ablation
Catheters
China
Clinical Observations
Humans
Patient compliance
Questionnaires
Regression analysis
Risk Factors
Stroke - drug therapy
Thromboembolism
Thrombosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5476-fc118a0b506d53dc296a06d1b323979feb50ef765427eafe3d28e0f34c7ead4e3
cites cdi_FETCH-LOGICAL-c5476-fc118a0b506d53dc296a06d1b323979feb50ef765427eafe3d28e0f34c7ead4e3
container_end_page 1991
container_issue 16
container_start_page 1989
container_title Chinese medical journal
container_volume 133
creator Hu, Zhi-Cheng
Liu, Shang-Yu
Wu, Ling-Min
Shen, Li-Shui
Liu, Li-Min
Li, Guo-Liang
Zheng, Li-Hui
Yao, Yan
description In patients with AF, anxiety mainly arises from fear of both symptoms of AF and thromboembolic events. Since anticoagulation is the primary method to prevent thromboembolic events, it is reasonable that anxiety makes patients with AF adhere to NOAC treatment. The reason for early anticoagulant therapy after AF ablation is to prevent thromboembolic events caused by endocardial injury from ablation and AF rhythm. [...]physicians need to clarify this and emphasize the importance of anticoagulant therapy to patients. [...]selection bias may be present as patients were recruited from a single medical center.
doi_str_mv 10.1097/CM9.0000000000001000
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6ed6e3421b114b9e95d12fc3b9d0d535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6ed6e3421b114b9e95d12fc3b9d0d535</doaj_id><sourcerecordid>2480933470</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5476-fc118a0b506d53dc296a06d1b323979feb50ef765427eafe3d28e0f34c7ead4e3</originalsourceid><addsrcrecordid>eNpdks1u1DAQxyMEokvhDRCyxIVLir_irC9IaEWhoogLnC3HmSResvbiOK36Ijwvk-5S2lqyPPb85zf2eIriNaNnjOr6_eabPqP3BsP5pFjxSvKyUpI9LVZUKFUqrfVJ8WKatpTyqqrV8-JE8DVXUqlV8efcuhzTRHzoxhmC86Enth0goQ0kRxJiKK98tjsfyFdiQ7Z9DH7KJCY7Lnvvou3nEa2FQvIABGwab8geko8tsV2GRGxOHvWdb5IfR5t9DMRZFN86m-MJxm8GH-zL4llnxwleHdfT4uf5px-bL-Xl988Xm4-XpatkrcrOMba2tKmoaivROq6VRZM1ggtd6w7QA12tsCY12A5Ey9dAOyEdblsJ4rS4OHDbaLdmn_zOphsTrTe3BzH1xiZ84QhGQatASM4axmSjQVct450TjW4pJq-Q9eHA2s_NDloHIWOFHkAfeoIfTB-vTC0V54wi4N0RkOLvGaZsdn5ygNUKEOfJcCmU0FKxJdfbR9JtnFPAUqFqTbUQsl6A8qByKU5Tgu7uMoyapYkMNpF53EQY9ub-Q-6C_nXNf-51HPH7pl_jfA3JDGDHPCw8jhegJaec0jXOciEr8Rf-ntT3</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2480933470</pqid></control><display><type>article</type><title>Factors influencing adherence to non-vitamin K antagonist oral anticoagulants in the early period after atrial fibrillation catheter ablation in China</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><source>PubMed Central Free</source><source>Publicly Available Content (ProQuest)</source><creator>Hu, Zhi-Cheng ; Liu, Shang-Yu ; Wu, Ling-Min ; Shen, Li-Shui ; Liu, Li-Min ; Li, Guo-Liang ; Zheng, Li-Hui ; Yao, Yan</creator><creatorcontrib>Hu, Zhi-Cheng ; Liu, Shang-Yu ; Wu, Ling-Min ; Shen, Li-Shui ; Liu, Li-Min ; Li, Guo-Liang ; Zheng, Li-Hui ; Yao, Yan</creatorcontrib><description>In patients with AF, anxiety mainly arises from fear of both symptoms of AF and thromboembolic events. Since anticoagulation is the primary method to prevent thromboembolic events, it is reasonable that anxiety makes patients with AF adhere to NOAC treatment. The reason for early anticoagulant therapy after AF ablation is to prevent thromboembolic events caused by endocardial injury from ablation and AF rhythm. [...]physicians need to clarify this and emphasize the importance of anticoagulant therapy to patients. [...]selection bias may be present as patients were recruited from a single medical center.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.1097/CM9.0000000000001000</identifier><identifier>PMID: 32826466</identifier><language>eng</language><publisher>China: Lippincott Williams &amp; Wilkins</publisher><subject>Ablation ; Administration, Oral ; Anticoagulants ; Anticoagulants - therapeutic use ; Anxiety ; Atrial Fibrillation - drug therapy ; Atrial Fibrillation - surgery ; Cardiac arrhythmia ; Catheter Ablation ; Catheters ; China ; Clinical Observations ; Humans ; Patient compliance ; Questionnaires ; Regression analysis ; Risk Factors ; Stroke - drug therapy ; Thromboembolism ; Thrombosis</subject><ispartof>Chinese medical journal, 2020-08, Vol.133 (16), p.1989-1991</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><rights>Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5476-fc118a0b506d53dc296a06d1b323979feb50ef765427eafe3d28e0f34c7ead4e3</citedby><cites>FETCH-LOGICAL-c5476-fc118a0b506d53dc296a06d1b323979feb50ef765427eafe3d28e0f34c7ead4e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462210/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2480933470?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32826466$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hu, Zhi-Cheng</creatorcontrib><creatorcontrib>Liu, Shang-Yu</creatorcontrib><creatorcontrib>Wu, Ling-Min</creatorcontrib><creatorcontrib>Shen, Li-Shui</creatorcontrib><creatorcontrib>Liu, Li-Min</creatorcontrib><creatorcontrib>Li, Guo-Liang</creatorcontrib><creatorcontrib>Zheng, Li-Hui</creatorcontrib><creatorcontrib>Yao, Yan</creatorcontrib><title>Factors influencing adherence to non-vitamin K antagonist oral anticoagulants in the early period after atrial fibrillation catheter ablation in China</title><title>Chinese medical journal</title><addtitle>Chin Med J (Engl)</addtitle><description>In patients with AF, anxiety mainly arises from fear of both symptoms of AF and thromboembolic events. Since anticoagulation is the primary method to prevent thromboembolic events, it is reasonable that anxiety makes patients with AF adhere to NOAC treatment. The reason for early anticoagulant therapy after AF ablation is to prevent thromboembolic events caused by endocardial injury from ablation and AF rhythm. [...]physicians need to clarify this and emphasize the importance of anticoagulant therapy to patients. [...]selection bias may be present as patients were recruited from a single medical center.</description><subject>Ablation</subject><subject>Administration, Oral</subject><subject>Anticoagulants</subject><subject>Anticoagulants - therapeutic use</subject><subject>Anxiety</subject><subject>Atrial Fibrillation - drug therapy</subject><subject>Atrial Fibrillation - surgery</subject><subject>Cardiac arrhythmia</subject><subject>Catheter Ablation</subject><subject>Catheters</subject><subject>China</subject><subject>Clinical Observations</subject><subject>Humans</subject><subject>Patient compliance</subject><subject>Questionnaires</subject><subject>Regression analysis</subject><subject>Risk Factors</subject><subject>Stroke - drug therapy</subject><subject>Thromboembolism</subject><subject>Thrombosis</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdks1u1DAQxyMEokvhDRCyxIVLir_irC9IaEWhoogLnC3HmSResvbiOK36Ijwvk-5S2lqyPPb85zf2eIriNaNnjOr6_eabPqP3BsP5pFjxSvKyUpI9LVZUKFUqrfVJ8WKatpTyqqrV8-JE8DVXUqlV8efcuhzTRHzoxhmC86Enth0goQ0kRxJiKK98tjsfyFdiQ7Z9DH7KJCY7Lnvvou3nEa2FQvIABGwab8geko8tsV2GRGxOHvWdb5IfR5t9DMRZFN86m-MJxm8GH-zL4llnxwleHdfT4uf5px-bL-Xl988Xm4-XpatkrcrOMba2tKmoaivROq6VRZM1ggtd6w7QA12tsCY12A5Ey9dAOyEdblsJ4rS4OHDbaLdmn_zOphsTrTe3BzH1xiZ84QhGQatASM4axmSjQVct450TjW4pJq-Q9eHA2s_NDloHIWOFHkAfeoIfTB-vTC0V54wi4N0RkOLvGaZsdn5ygNUKEOfJcCmU0FKxJdfbR9JtnFPAUqFqTbUQsl6A8qByKU5Tgu7uMoyapYkMNpF53EQY9ub-Q-6C_nXNf-51HPH7pl_jfA3JDGDHPCw8jhegJaec0jXOciEr8Rf-ntT3</recordid><startdate>20200820</startdate><enddate>20200820</enddate><creator>Hu, Zhi-Cheng</creator><creator>Liu, Shang-Yu</creator><creator>Wu, Ling-Min</creator><creator>Shen, Li-Shui</creator><creator>Liu, Li-Min</creator><creator>Li, Guo-Liang</creator><creator>Zheng, Li-Hui</creator><creator>Yao, Yan</creator><general>Lippincott Williams &amp; Wilkins</general><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><general>Wolters Kluwer</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200820</creationdate><title>Factors influencing adherence to non-vitamin K antagonist oral anticoagulants in the early period after atrial fibrillation catheter ablation in China</title><author>Hu, Zhi-Cheng ; Liu, Shang-Yu ; Wu, Ling-Min ; Shen, Li-Shui ; Liu, Li-Min ; Li, Guo-Liang ; Zheng, Li-Hui ; Yao, Yan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5476-fc118a0b506d53dc296a06d1b323979feb50ef765427eafe3d28e0f34c7ead4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Ablation</topic><topic>Administration, Oral</topic><topic>Anticoagulants</topic><topic>Anticoagulants - therapeutic use</topic><topic>Anxiety</topic><topic>Atrial Fibrillation - drug therapy</topic><topic>Atrial Fibrillation - surgery</topic><topic>Cardiac arrhythmia</topic><topic>Catheter Ablation</topic><topic>Catheters</topic><topic>China</topic><topic>Clinical Observations</topic><topic>Humans</topic><topic>Patient compliance</topic><topic>Questionnaires</topic><topic>Regression analysis</topic><topic>Risk Factors</topic><topic>Stroke - drug therapy</topic><topic>Thromboembolism</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hu, Zhi-Cheng</creatorcontrib><creatorcontrib>Liu, Shang-Yu</creatorcontrib><creatorcontrib>Wu, Ling-Min</creatorcontrib><creatorcontrib>Shen, Li-Shui</creatorcontrib><creatorcontrib>Liu, Li-Min</creatorcontrib><creatorcontrib>Li, Guo-Liang</creatorcontrib><creatorcontrib>Zheng, Li-Hui</creatorcontrib><creatorcontrib>Yao, Yan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hu, Zhi-Cheng</au><au>Liu, Shang-Yu</au><au>Wu, Ling-Min</au><au>Shen, Li-Shui</au><au>Liu, Li-Min</au><au>Li, Guo-Liang</au><au>Zheng, Li-Hui</au><au>Yao, Yan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors influencing adherence to non-vitamin K antagonist oral anticoagulants in the early period after atrial fibrillation catheter ablation in China</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chin Med J (Engl)</addtitle><date>2020-08-20</date><risdate>2020</risdate><volume>133</volume><issue>16</issue><spage>1989</spage><epage>1991</epage><pages>1989-1991</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>In patients with AF, anxiety mainly arises from fear of both symptoms of AF and thromboembolic events. Since anticoagulation is the primary method to prevent thromboembolic events, it is reasonable that anxiety makes patients with AF adhere to NOAC treatment. The reason for early anticoagulant therapy after AF ablation is to prevent thromboembolic events caused by endocardial injury from ablation and AF rhythm. [...]physicians need to clarify this and emphasize the importance of anticoagulant therapy to patients. [...]selection bias may be present as patients were recruited from a single medical center.</abstract><cop>China</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>32826466</pmid><doi>10.1097/CM9.0000000000001000</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0366-6999
ispartof Chinese medical journal, 2020-08, Vol.133 (16), p.1989-1991
issn 0366-6999
2542-5641
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6ed6e3421b114b9e95d12fc3b9d0d535
source HEAL-Link subscriptions: Lippincott Williams & Wilkins; PubMed Central Free; Publicly Available Content (ProQuest)
subjects Ablation
Administration, Oral
Anticoagulants
Anticoagulants - therapeutic use
Anxiety
Atrial Fibrillation - drug therapy
Atrial Fibrillation - surgery
Cardiac arrhythmia
Catheter Ablation
Catheters
China
Clinical Observations
Humans
Patient compliance
Questionnaires
Regression analysis
Risk Factors
Stroke - drug therapy
Thromboembolism
Thrombosis
title Factors influencing adherence to non-vitamin K antagonist oral anticoagulants in the early period after atrial fibrillation catheter ablation in China
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T01%3A01%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20influencing%20adherence%20to%20non-vitamin%20K%20antagonist%20oral%20anticoagulants%20in%20the%20early%20period%20after%20atrial%20fibrillation%20catheter%20ablation%20in%20China&rft.jtitle=Chinese%20medical%20journal&rft.au=Hu,%20Zhi-Cheng&rft.date=2020-08-20&rft.volume=133&rft.issue=16&rft.spage=1989&rft.epage=1991&rft.pages=1989-1991&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.1097/CM9.0000000000001000&rft_dat=%3Cproquest_doaj_%3E2480933470%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5476-fc118a0b506d53dc296a06d1b323979feb50ef765427eafe3d28e0f34c7ead4e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2480933470&rft_id=info:pmid/32826466&rfr_iscdi=true